zuranolone   Click here for help

GtoPdb Ligand ID: 12858

Synonyms: compound 3 [PMID: 28753313] | SAGE-217 | SAGE217 | Zurzuvae®
Approved drug
zuranolone is an approved drug (FDA (2023))
Compound class: Synthetic organic
Comment: Zuranolone (SAGE-217) is a novel, rapid-acting, oral antipsychotic [1]. It is a neuroactive steroid that acts as a positive allosteric modulator of synaptic and extrasynaptic GABAA receptors [2,4].
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 76.69
Molecular weight 409.57
XLogP 5.61
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES C[C@]1(CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC[C@@H]4C(=O)CN5C=C(C#N)C=N5)C1)O
Isomeric SMILES C[C@]1(CC[C@H]2[C@@H](C1)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4C(=O)CN5C=C(C=N5)C#N)C)O
InChI InChI=1S/C25H35N3O2/c1-24(30)9-7-18-17(11-24)3-4-20-19(18)8-10-25(2)21(20)5-6-22(25)23(29)15-28-14-16(12-26)13-27-28/h13-14,17-22,30H,3-11,15H2,1-2H3/t17-,18+,19-,20-,21+,22-,24-,25+/m1/s1
InChI Key HARRKNSQXBRBGZ-GVKWWOCJSA-N
References
1. Carvalho T. (2023)
New depression drug zuranolone one step closer to FDA ruling.
Nat Med, 29 (5): 1032-1033. [PMID:37041352]
2. Cutler AJ, Mattingly GW, Maletic V. (2023)
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder.
Transl Psychiatry, 13 (1): 228. [PMID:37365161]
3. Deligiannidis KM, Meltzer-Brody S, Maximos B, Peeper EQ, Freeman M, Lasser R, Bullock A, Kotecha M, Li S, Forrestal F et al.. (2023)
Zuranolone for the Treatment of Postpartum Depression.
Am J Psychiatry, 180 (9): 668-675. [PMID:37491938]
4. Martinez Botella G, Salituro FG, Harrison BL, Beresis RT, Bai Z, Blanco MJ, Belfort GM, Dai J, Loya CM, Ackley MA et al.. (2017)
Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor.
J Med Chem, 60 (18): 7810-7819. [PMID:28753313]